Literature DB >> 10550647

Signs, symptoms and course of normal pressure hydrocephalus in comparison with cerebral atrophy.

U Meier1, F S Zeilinger, D Kintzel.   

Abstract

Between May 1982 and January 1997 we investigated 200 patients for normal pressure hydrocephalus (NPH) by performing an intrathecal infusion test. 168 patients (84%) presented with the clinical syndrome of gait ataxia, dementia and urinary incontinence, the so called Adams triad. In 107 patients (54%) the diagnosis of a NPH could be confirmed. Of these, 102 patients (95%) underwent a shunt operation. In a follow-up (7 month and 3 years later) we interviewed the patients or their relatives about the progression of the disease. At those time intervals we could evaluate the improvement after shunt operation or infusion test. In our experience gait ataxia is the guiding sign of NPH. Regarding dementia we could not find a significant difference compared to cerebral atrophy. Urinary incontinence can be characterized as a symptom of late stage NPH. The complete Adams triad should not be overestimated in differential diagnostic considerations. Subdivision of NPH into an early stage and a late stage allows one to conclude prognostic evaluations about the course of the disease. Patients with an early stage NPH reported at the follow-up an improvement of their symptoms after shunt operation in 65 percent and those with a late stage NPH in 50 percent. The computer aided infusion test allows a safe differentiation between patients with NPH and those with cerebral atrophy.

Entities:  

Mesh:

Year:  1999        PMID: 10550647     DOI: 10.1007/s007010050480

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  10 in total

1.  Is there a correlation between operative results and change in ventricular volume after shunt placement? A study of 60 cases of idiopathic normal-pressure hydrocephalus.

Authors:  U Meier; S Paris; A Gräwe; D Stockheim; A Hajdukova; S Mutze
Journal:  Neuroradiology       Date:  2003-05-16       Impact factor: 2.804

2.  [Gravity valves for idiopathic normal pressure hydrocephalus. A Prospective study of 60 patients].

Authors:  U Meier
Journal:  Nervenarzt       Date:  2004-06       Impact factor: 1.214

3.  Ventricular dilation: association with gait and cognition.

Authors:  Walter M Palm; Jane S Saczynski; J van der Grond; Sigurdur Sigurdsson; Olafur Kjartansson; Palmi V Jonsson; Gudny Eiriksdottir; Vilmundur Gudnason; Faiza Admiraal-Behloul; Lenore J Launer; Mark A van Buchem
Journal:  Ann Neurol       Date:  2009-10       Impact factor: 10.422

Review 4.  [Hydrocephalus and intracranial hypotension].

Authors:  W Reith; U Yilmaz
Journal:  Radiologe       Date:  2012-09       Impact factor: 0.635

5.  NPH Log: Validation of a New Assessment Tool Leading to Earlier Diagnosis of Normal Pressure Hydrocephalus.

Authors:  Ignacio Jusué-Torres; Jennifer Lu; Jamie Robison; Jamie B Hoffberger; Alicia Hulbert; Abanti Sanyal; Jan Wemmer; Benjamin D Elder; Daniele Rigamonti
Journal:  Cureus       Date:  2016-06-27

Review 6.  Endoscopic third ventriculostomy (ETV) for idiopathic normal pressure hydrocephalus (iNPH).

Authors:  Katarina Ivana Tudor; Mario Tudor; Jenny McCleery; Josip Car
Journal:  Cochrane Database Syst Rev       Date:  2015-07-29

7.  Indications for valve-pressure adjustments of gravitational assisted valves in patients with idiopathic normal pressure hydrocephalus.

Authors:  Leonie Gölz; Johannes Lemcke; Ullrich Meier
Journal:  Surg Neurol Int       Date:  2013-10-15

8.  Endoscopic Third Ventriculostomy in Normal Pressure Hydrocephalus and Symptomatic Long-standing Overt Ventriculomegaly.

Authors:  Mustafa Balevi
Journal:  Asian J Neurosurg       Date:  2017 Oct-Dec

9.  Ventriculoperitoneal shunt malfunction due to chronic cholecystitis: A case report.

Authors:  Qi Yu; Chengjian Lou; Tianda Feng; Yunhui Liu
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

10.  Efficacy and safety of programmable compared with fixed anti-siphon devices for treating idiopathic normal-pressure hydrocephalus (iNPH) in adults - SYGRAVA: study protocol for a randomized trial.

Authors:  Romy Scholz; Johannes Lemcke; Ullrich Meier; Dirk Stengel
Journal:  Trials       Date:  2018-10-17       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.